Vanguard
http://www.vanguard.com/Vanguard, an investment management company, offers mutual funds and other financial products and services to institutional and individual investors worldwide.
View Older Stories View More Recent Stories
-
Form N-MFP2 VANGUARD MONEY MARKET For: Nov 30
-
Form N-MFP2 VANGUARD MUNICIPAL BOND For: Nov 30
-
Form N-MFP2 VANGUARD CMT FUNDS For: Nov 30
-
Form N-MFP2 VANGUARD CMT FUNDS For: Nov 30
-
Form N-MFP2 VANGUARD MONEY MARKET For: Nov 30
-
Form N-MFP2 VANGUARD ADMIRAL FUNDS For: Nov 30
-
Form N-MFP2 VANGUARD CALIFORNIA TAX- For: Nov 30
-
AlphaRoot Launches Management Liability Insurance Program Calibrated to the Cannabis Industry
-
Latest Tech Key in Helping Solve Healthcare’s Largest Pain Point
-
Keeper Security Partners with TraitWare to Provide Passwordless MFA with Single Sign-On for Enterprise Zero-Knowledge Security
-
Bain & Company and NPS Creator, Fred Reichheld, Reveal the Unbeatable Strategy of Loving Customers in Reichheld's Most Provocative Book Yet
-
VR Digital Therapeutics for depression developed in consultation with specialists from Boston, MA, U.S.A., introducing innovative clinical tool at CES2022
-
The Capital Group Launches GovConHealth Platform to Transform Access to Healthcare Benefits for Federal Government Contractors
-
View, Inc. (VIEW) Acquires RXR Realty’s WorxWell Platform
-
View Acquires RXR Realty’s WorxWell™ Platform to Create an Industry-Leading Office Real Estate Technology Offering
-
View Acquires RXR Realty’s WorxWell™ Platform to Create an Industry-Leading Office Real Estate Technology Offering
-
Crypto-Friendly Fintech Wirex Looks to Metaverse with Whitepaper Launch and 5BN 'DeFi-Ready' Digital Currency Investment
-
Latest Tech Key in Helping Solve Healthcare's Largest Pain Point
-
Horns with Heart Announces $800,000 Sponsorship for Texas Longhorn Offensive Line Beginning in 2022
-
Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Cold Tumors Including Pancreatic and Ovarian Cancers for Anti-CTLA-4 Monoclonal Antibody, ADG116, at ESMO-IO
-
Omnicom Public Relations Group Sweeps Global AMEC and ICCO Awards Recognizing Exceptional Achievement in Communications Excellence and Measurement
-
State Street Digital, Vanguard and Symbiont Complete First Live Trade for Foreign Exchange Forward Contracts Leveraging Revolutionary Blockchain Technology and Smart Contracts
-
BRP Group, Inc. Announces Launch of $250 Million Term Loan B Add-On
-
Adagene Inc. (ADAG) Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Treatment-Resistant Tumors for Anti-CTLA-4 Monoclonal Antibody, ADG116, at ESMO
-
Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Treatment-Resistant Tumors for Anti-CTLA-4 Monoclonal Antibody, ADG116, at ESMO-IO 2021
-
Form MA-I VANGUARD ADVISERS INC
-
John Cho to Receive Lexus Legacy Award at 19th Annual Unforgettable Gala Presented by Lexus
-
Vanguard Gastroenterology in Manhattan Emphasizes Importance of Colon Cancer Screenings Given Findings of Increased Early-onset Colon Cancer Rates Reported in JAMA
-
Yext, Inc. Announces Third Quarter Fiscal 2022 Results
-
RetireOne Partners with Wade Pfau on Whitepaper, "Unbundling Investments from Insurance to Solve for Lifetime Sequence-of-Return Risk"
-
Doritos® and Twitch Rivals North America Take This Year's Doritos Bowl to Another Level®
-
BRP Group, Inc. Completes Acquisitions of Construction Risk Partners and Wood Gutmann & Bogart Insurance Brokers
-
AWS Announces Six New Amazon SageMaker Capabilities
-
Vanguard Charitable Launches Updated Nonprofit Aid Visualizer™ Tool (NAVi) to Help Donors Connect to Nonprofits Providing Hunger and Homelessness Relief
-
mintBlue selected by VISMA | yuki to integrate blockchain-based functionalities to cloud accounting platform
-
Form TA-1/A VANGUARD GROUP INC
-
Compass Appoints Frank Martell, President and CEO of CoreLogic, to Board of Directors
-
Form N-CSR VANGUARD HORIZON FUNDS For: Sep 30
-
Form N-CSR VANGUARD QUANTITATIVE For: Sep 30
-
Form N-CSR VANGUARD FENWAY FUNDS For: Sep 30
-
Form N-CSR VANGUARD MALVERN FUNDS For: Sep 30
-
Form N-CSR VANGUARD WELLESLEY INCOM For: Sep 30
-
Form N-CSR VANGUARD CHESTER FUNDS For: Sep 30
-
Indian School of Hospitality with Sommet Education Kick-off Development Plans for India Region
-
Indian School of Hospitality with Sommet Education Kick-off Development Plans for India Region
-
Adagene Inc. (ADAG) Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab
-
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab
-
Form NPORT-P VANGUARD VALLEY FORGE For: Sep 30
-
Form NPORT-P VANGUARD BOND INDEX FUND For: Sep 30
-
Form NPORT-P VANGUARD VARIABLE INSURA For: Sep 30

